CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended
	Nov. 30, 2012	Nov. 30, 2011
Cash flows from operating activities
Net loss	$ (1,358,600)	$ (1,952,078)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation	0	1,087
Stock-based compensation	326,329	991,488
Interest expense from amortization of discount on convertible debentures	5,000	20,000
Change in fair value of derivative liability	(88,663)	81,073
Gain on extinguishment of liabilities	(133,540)	(159,552)
Gain on disposition of equipment	(1,500)	0
Changes in assets and liabilities
Grant receivable	303,102	(272,127)
Other current assets	(695)	(1,667)
Accounts payable and accrued liabilities	108,330	101,973
Deferred revenue	(49,318)	(49,317)
Net cash used in operating activities	(889,555)	(1,239,120)
Cash flows from investing activities
Payments for in-process research and development	0	(265,000)
Proceeds from disposition of equipment	1,500	0
Net cash provided by (used in) investing activities	1,500	(265,000)
Cash flows from financing activities
Proceeds from the exercise of stock warrants	934,130	1,210,990
Increase (decrease) in advance from debenture holder	(251,930)	64,080
Net cash provided by financing activities	682,200	1,275,070
Net decrease in cash and cash equivalents	(205,855)	(229,050)
Cash and cash equivalents at beginning of year	405,327	634,377
Cash and cash equivalents at end of year	199,472	405,327
Supplemental Disclosures of Cash Flow Information:
Cash paid for interest	3,245	3,579
Noncash Investing and Financing Activities:
Issuance of common stock for conversion of 4.75% debentures	8,570	11,110
Conversion of Series B preferred stock into common stock	769,690	0
Conversion of Series I preferred stock into common stock	573,400	0
Issuance of common stock in settlement of preferred dividends	$ 30,000	$ 0